Rohto Pharmaceutical Co Ltd - Company Profile
Powered by
All the data and insights you need on Rohto Pharmaceutical Co Ltd in one report.
- Save hours of research time and resources with
our up-to-date Rohto Pharmaceutical Co Ltd Strategy Report
- Understand Rohto Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Rohto Pharmaceutical Catalyst Calendar
Proactively evaluate Rohto Pharmaceutical Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Rohto Pharmaceutical Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
31 Oct 2021 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
01 Jun 2021 | Phase II Trial Initiation | Rohto Pharmaceutical Co Ltd | 4527 | ADR-001 | Infectious Disease | Coronavirus Disease 2019 (COVID-19); Coronavirus Disease 2019 (COVID-19) Pneumonia | Clinical Trial Registry |
01 Sep 2020 | Phase I Trial Initiation | Rohto Pharmaceutical Co Ltd | 4527 | ADR-001 | Infectious Disease | Coronavirus Disease 2019 (COVID-19); Coronavirus Disease 2019 (COVID-19) Pneumonia | Clinical Trial Registry |
15 Jun 2020 | Phase I Trial Initiation | Nagoya University; Rohto Pharmaceutical Co Ltd | 4527 | ADR-001 | Genito Urinary System And Sex Hormones | Glomerulonephritis; IgA Nephropathy (Berger's Disease) | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer